Archford Capital Strategies, LLC Abb Vie Inc. Transaction History

Archford Capital Strategies, LLC

$681 Million
Q3 2024

A detailed history of Archford Capital Strategies, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Archford Capital Strategies, LLC holds 5,581 shares of ABBV stock, worth $993,473. This represents 0.16% of its overall portfolio holdings.

Number of Shares

5,581

Previous 5,753 2.99%

Holding current value

$993,473

Previous $986,000 11.76%

% of portfolio

0.16%

Previous 0.16%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$163.84 - $199.33 $28,180 - $34,284	-172 Reduced 2.99%	5,581 $1.1 Million
Q2 2024 Jul 17, 2024	SELL	$154.79 - $180.76 $1.18 Million - $1.38 Million	-7,654 Reduced 57.09%	5,753 $986,000
Q1 2024 Apr 24, 2024	BUY	$159.82 - $182.1 $114,111 - $130,019	714 Added 5.63%	13,407 $2.44 Million
Q4 2023 Jan 12, 2024	BUY	$137.6 - $154.97 $249,056 - $280,495	1,810 Added 16.63%	12,693 $1.97 Million
Q3 2023 Oct 27, 2023	SELL	$133.59 - $154.65 $104,200 - $120,627	-780 Reduced 6.69%	10,883 $1.62 Million
Q2 2023 Aug 02, 2023	SELL	$132.51 - $164.9 $3,445 - $4,287	-26 Reduced 0.22%	11,663 $1.57 Million
Q1 2023 Apr 18, 2023	BUY	$144.61 - $166.54 $229,785 - $264,632	1,589 Added 15.73%	11,689 $1.86 Million
Q4 2022 Jan 26, 2023	BUY	$138.31 - $165.87 $193,910 - $232,549	1,402 Added 16.12%	10,100 $0
Q3 2022 Oct 17, 2022	SELL	$134.21 - $153.93 $3,221 - $3,694	-24 Reduced 0.28%	8,698 $1.17 Million
Q2 2022 Jul 12, 2022	BUY	$137.62 - $174.96 $142,987 - $181,783	1,039 Added 13.52%	8,722 $1.34 Million
Q1 2022 Apr 18, 2022	BUY	$131.98 - $163.75 $62,030 - $76,962	470 Added 6.52%	7,683 $1.26 Million
Q4 2021 Jan 20, 2022	BUY	$107.43 - $135.93 $34,055 - $43,089	317 Added 4.6%	7,213 $977,000
Q3 2021 Oct 14, 2021	BUY	$106.4 - $120.78 $38,091 - $43,239	358 Added 5.48%	6,896 $744,000
Q2 2021 Jul 23, 2021	BUY	$105.21 - $117.21 $45,135 - $50,283	429 Added 7.02%	6,538 $736,000
Q1 2021 Apr 26, 2021	SELL	$102.3 - $112.62 $2.22 Million - $2.45 Million	-21,749 Reduced 78.07%	6,109 $653,000
Q4 2020 Jan 19, 2021	BUY	$80.49 - $108.67 $1,046 - $1,412	13 Added 0.05%	27,858 $2.99 Million
Q3 2020 Oct 19, 2020	BUY	$85.91 - $100.83 $257 - $302	3 Added 0.01%	27,845 $2.44 Million
Q2 2020 Jul 24, 2020	SELL	$73.37 - $98.18 $17,535 - $23,465	-239 Reduced 0.85%	27,842 $2.73 Million
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $5,031 - $7,627	-78 Reduced 0.28%	28,081 $2.14 Million
Q4 2019 Jan 15, 2020	SELL	$72.13 - $90.25 $9,232 - $11,552	-128 Reduced 0.45%	28,159 $2.49 Million
Q3 2019 Oct 23, 2019	BUY	$62.98 - $75.72 $1,889 - $2,271	30 Added 0.11%	28,287 $2.14 Million
Q2 2019 Jul 18, 2019	BUY	$65.7 - $83.98 $56,502 - $72,222	860 Added 3.14%	28,257 $2.06 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $21,753 - $25,602	-282 Reduced 1.02%	27,397 $2.21 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $159,826 - $197,108	-2,053 Reduced 6.91%	27,679 $2.55 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $214,362 - $238,303	-2,411 Reduced 7.5%	29,732 $2.81 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $398,174 - $471,130	4,435 Added 16.01%	32,143 $2.98 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $3,220 - $4,312	35 Added 0.13%	27,708 $2.68 Million
Q4 2017 Feb 16, 2018	SELL	$89.56 - $98.21 $13,613 - $14,927	-152 Reduced 0.55%	27,673 $2.68 Million
Q3 2017 Nov 17, 2017	BUY	$69.85 - $89.22 $9,569 - $12,223	137 Added 0.49%	27,825 $2.47 Million
Q2 2017 Aug 25, 2017	SELL	N/A	-35 Reduced 0.13%	27,688 $2.01 Million
Q2 2017 Aug 18, 2017	BUY	N/A	26,465 Added 2103.74%	27,723 $359,000
Q2 2017 Aug 18, 2017	BUY	N/A	1,258	1,258 $52,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Archford Capital Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Archford Capital Strategies, LLC with notifications on news.

Account

Archford Capital Strategies, LLC Abb Vie Inc. Transaction History